REPRISE III - A prospective randomised investigation of a novel TAVI system

Summary

A pivotal trial which for the first time compares – head-to-head, valve-to-valve – the LOTUS valve with the self-expanding CoreValve. Join T. Feldman and learn whether non-inferiority or primary effectiveness was reached. Find out who was included in this global trial and discover results such as 30-day safety and 1-year effectiveness; hear about the effectiveness of LOTUS in relation to stroke or paravalvular leak; or the high performance of CoreValve when it comes to pacing or haemodynamics. Learn more here…